- Home
- GERN vs GDEN Comparison
GERN vs GDEN Comparison
Compare GERN & GDEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- GDEN
- Stock Information
- Founded
- GERN 1990
- GDEN 1998
- Country
- GERN United States
- GDEN United States
- Employees
- GERN N/A
- GDEN N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- GDEN Services-Misc. Amusement & Recreation
- Sector
- GERN Health Care
- GDEN Consumer Discretionary
- Exchange
- GERN Nasdaq
- GDEN Nasdaq
- Market Cap
- GERN 853.5M
- GDEN 725.6M
- IPO Year
- GERN 1996
- GDEN 1999
- Fundamental
- Price
- GERN $1.51
- GDEN $28.98
- Analyst Decision
- GERN Buy
- GDEN Buy
- Analyst Count
- GERN 7
- GDEN 6
- Target Price
- GERN $4.17
- GDEN $37.00
- AVG Volume (30 Days)
- GERN 10.9M
- GDEN 198.2K
- Earning Date
- GERN 08-07-2025
- GDEN 08-07-2025
- Dividend Yield
- GERN N/A
- GDEN 3.50%
- EPS Growth
- GERN N/A
- GDEN N/A
- EPS
- GERN N/A
- GDEN 0.39
- Revenue
- GERN $116,293,000.00
- GDEN $653,614,000.00
- Revenue This Year
- GERN $160.12
- GDEN $1.48
- Revenue Next Year
- GERN $55.01
- GDEN $2.88
- P/E Ratio
- GERN N/A
- GDEN $74.60
- Revenue Growth
- GERN 22264.04
- GDEN N/A
- 52 Week Low
- GERN $1.17
- GDEN $22.66
- 52 Week High
- GERN $5.06
- GDEN $35.49
- Technical
- Relative Strength Index (RSI)
- GERN 51.36
- GDEN 59.86
- Support Level
- GERN $1.42
- GDEN $26.81
- Resistance Level
- GERN $1.58
- GDEN $28.15
- Average True Range (ATR)
- GERN 0.10
- GDEN 0.80
- MACD
- GERN -0.01
- GDEN 0.09
- Stochastic Oscillator
- GERN 40.00
- GDEN 88.97
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.